APA (7th ed.) Citation

TBC, M., MC, B., JP, P., & MI, A. (2022). Double heterozygous pathogenic variants prevalence in a cohort of patients with hereditary breast cancer. Frontiers in oncology, 12, 873395. https://doi.org/10.3389/fonc.2022.873395

Chicago Style (17th ed.) Citation

TBC, Megid, Barros-Filho MC, Pisani JP, and Achatz MI. "Double Heterozygous Pathogenic Variants Prevalence in a Cohort of Patients with Hereditary Breast Cancer." Frontiers in Oncology 12 (2022): 873395. https://doi.org/10.3389/fonc.2022.873395.

MLA (9th ed.) Citation

TBC, Megid, et al. "Double Heterozygous Pathogenic Variants Prevalence in a Cohort of Patients with Hereditary Breast Cancer." Frontiers in Oncology, vol. 12, 2022, p. 873395, https://doi.org/10.3389/fonc.2022.873395.